iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery & development.

Through advanced AI and photonics, we collect massive amounts of data to build a digital library of biomarkers & biological profiles to get life-saving personalized treatments to patients faster.

Our technology detects label-free nanosized biomarkers in biological liquid samples, to generate specific patient or disease signatures.

The current project focuses on developing an Alzheimer’s disease (AD) clinical trial patient screening tool, making it comfortable for the patient while affordable and efficient for the industry, saving 40% cost and 70% time.